Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers

Drug Discovery Today

Volumn 18, Issue 5-6, 2013, Pages 290-297

  Gan, Li ^a   Wang, Jing ^a,b   Jiang, Min ^a,b   Bartlett, Hanah ^c   Ouyang, Defang ^c   Eperjesi, Frank ^c   Liu, Jianping ^b   Gan, Yong ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CATIONORM; CATIOPROST; CUBOSOME; CYCLOSPORIN; CYCLOSPORIN A; DIFLUPREDNATE; LATANOPROST; LIPIMIX; LIPOSOME; NANOCARRIER; NIOSOME; RETINOL; SOOTHE; UNCLASSIFIED DRUG;

CORNEA PERFORATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRY EYE; EMULSION; GLAUCOMA; HUMAN; LIPID TRANSPORT; REVIEW; TOPICAL OPHTHALMIC DRUG DELIVERY;

ADMINISTRATION, OPHTHALMIC; ANIMALS; DRUG CARRIERS; HUMANS; LIPIDS; NANOPARTICLES; OPHTHALMIC SOLUTIONS;

EID: 84874679837     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.10.005     Document Type: Review

References (66)

1. P.M. Hughes Topical and systemic drug delivery to the posterior segments Adv. Drug Deliv. Rev. 57 2005 2010 2032
2. K. Hosoya Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation Eur. J. Pharm. Biopharm. 60 2005 227 240
3. T. Hagigit Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGF KDR receptors to the eye J. Control. Release 145 2010 297 305
4. J. Shen Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery J. Control. Release 137 2009 217 223
5. K. Hironaka Edaravone-loaded liposomes for retinal protection against oxidative stress-induced retinal damage Eur. J. Pharm. Biopharm. 79 2011 119 125
6. L. Gan Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results Int. J. Pharm. 365 2009 143 149
7. J. Zhang, and S.L. Wang Topical use of Coenzyme Q(10)-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract effect Int. J. Pharm. 372 2009 66 75
8. X. Li A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers Int. J. Pharm. 363 2008 177 182
9. Y. Kapoor, and A. Chauhan Ophthalmic delivery of cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels Int. J. Pharm. 361 2008 222 229
10. S.S. Mahmoud Liposomal phospholipid preparations of chloramphenicol for ophthalmic applications J. Pharm. Sci. 97 2008 2691 2701
11. P. Gershkovich A review of the application of lipid-based systems in systemic, dermal/transdermal, and ocular drug delivery Crit. Rev. Ther. Drug 25 2008 545 584
12. A. Seyfoddin Solid lipid nanoparticles for ocular drug delivery Drug Deliv. 17 2010 467 489
13. Y. Sultana Nanotechnology in ocular delivery: current and future directions Drugs Today 47 2011 441 455
14. E.B. Souto Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs Curr. Eye Res. 35 2010 537 552
15. S. Mishima Determination of tear volume and tear flow Invest. Ophthalmol. 5 1966 264 276
16. A. Ludwig The use of mucoadhesive polymers in ocular drug delivery Adv. Drug Deliv. Rev. 57 2005 1595 1639
17. I.K. Gipson, and P. Argüeso Role of mucins in the function of the corneal and conjunctival epithelia Int. Rev. Cytol. 231 2003 1 49
18. E. Mannermaa Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics Adv. Drug Deliv. Rev. 58 2006 1136 1163
19. A.J. Huang Paracellular permeability of corneal and conjunctival epithelia Invest. Ophthalmol. Vis. Sci. 30 1989 684 689
20. Hom, M.M. et al. (2003) Understanding emulsion eye drop technology. Available at: http://www.revoptom.com/content/d/news-review/c/18026/ dnnprintmode/true/?skinsrc=%5Bl%5Dskins/ro2009/pageprint&containersrc= %5Bl%5Dcontainers/ro2009/simple
21. M. de la Fuente Chitosan-based nanostructures: a delivery platform for ocular therapeutics Adv. Drug Deliv. Rev. 62 2010 100 117
22. R.G. Alany W/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention J. Control. Release 111 2006 145 152
23. S. Aoki Systemic FK506 improved tear secretion in dry eye associated with chronic graft versus host disease Br. J. Ophthalmol. 89 2005 243 244
24. Furness, G. (2004) Novagali cationic emulsions-a purely positive drug delivery system. Available at: http://www.touchhealthsciences.com/articles/ novagali-cationic-emulsions-purely-positive-drug-delivery-system
25. J. Jiao Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery Adv. Drug Deliv. Rev. 60 2008 1663 1673
26. S. Katragadda Modulation of P-glycoprotein-mediated efflux by prodrug derivatization: an approach involving peptide transporter-mediated influx across rabbit cornea J. Ocul. Pharmacol. Ther. 22 2006 110 120
27. M. Yamaguchi Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate Int. J. Pharm. 301 2005 121 128
28. J. Shen Novel NSAIDs ophthalmic formulation: flurbiprofen axetil emulsion with low irritancy and improved anti-inflammation effect Int. J. Pharm. 412 2011 115 122
29. M. Yamaguchi Mucoadhesive properties of chitosan-coated ophthalmic lipid emulsion containing indomethacin in tear fluid Biol. Pharm. Bull. 32 2009 1266 1271
30. S. Klang Influence of emulsion droplet surface charge on indomethacin ocular tissue distribution Pharm. Dev. Technol. 5 2000 521 532
31. D. Gulsen, and A. Chauhan Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle Int. J. Pharm. 292 2005 95 117
32. H.O. Ammar Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery Drug Dev. Ind. Pharm. 36 2010 1330 1339
33. P. Chetoni Liposome-encapsulated mitomycin C for the reduction of corneal healing rate and ocular toxicity J. Drug Deliv. Sci. Technol. 17 2007 43 48
34. F.S. Habib Liposomes as an ocular delivery system of fluconazole: in-vitro studies Acta Ophthalmol. 88 2010 901 904
35. R.M. Hathout Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies AAPS Pharmscitech. 8 2007 E1 E12
36. J. Zhang Freeze-dried liposomes as potential carriers for ocular administration of cytochrome c against selenite cataract formation J. Pharm. Pharmacol. 61 2009 1171 1178
37. S.L. Law Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption J. Control. Release 63 2000 135 140
38. W. Yan Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines Mol. Immunol. 44 2007 3672 3681
39. R. Cortesi Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity Int. J. Pharm. 317 2006 90 100
40. J. Zhang, and S. Wang Topical use of Coenzyme Q(10)-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract effect Int. J. Pharm. 372 2009 66 75
41. G. Abdelbary Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes Pharm. Dev. Technol. 16 2011 44 56
42. M.M. Mehanna Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment Drug Dev. Ind. Pharm. 36 2010 108 118
43. N. Li Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery Int. J. Pharm. 379 2009 131 138
44. S. Wang Protective effect of Coenzyme Q(10) against oxidative damage in human lens epithelial cells by novel ocular drug carriers Int. J. Pharm. 403 2011 219 229
45. G. Garg Cubosomes: an overview Biol. Pharm. Bull. 30 2007 350 353
46. L. Gan Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability Int. J. Pharm. 396 2010 179 187
47. A.S. Guinedi Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide Int. J. Pharm. 306 2005 71 82
48. D. Aggarwal Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor Int. J. Pharm. 338 2007 21 26
49. D. Aggarwal, and I.P. Kaur Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system Int. J. Pharm. 290 2005 155 159
50. A.A. Attama Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct Int. J. Pharm. 355 2008 307 313
51. R. Li A potential new therapeutic system for glaucoma: solid lipid nanoparticles containing methazolamide J. Microencapsul. 28 2011 134 141
52. E.H. Gokce Cyclosporine A-loaded solid lipid nanoparticles: ocular tolerance and in vivo drug release in rabbit eyes Curr. Eye Res. 34 2009 996 1003
53. Z. Liu Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo Drug Dev. Ind. Pharm. 37 2011 475 481
54. A. Seyfoddin, and R. Al-Kassas Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir Drug Dev. Ind. Pharm. 2012 10.3109/03639045.2012.665460 (Epub ahead of print)
55. M.A. Kalam Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system J. Drug Target. 18 2010 191 204
56. J. Shen Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: improving in vivo ocular distribution Int. J. Pharm. 402 2010 248 253
57. Q. Luo Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system Int. J. Pharm. 403 2011 185 191
58. E. Gonzalez-Mira Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery Nanotechnology 22 2011 045101 (Epub)
59. J. Araujo Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye Colloids Surf. B 88 2011 150 157
60. A.-L. Troutier, and C. Ladavière An overview of lipid membrane supported by colloidal particles Adv. Colloid Interface Sci. 133 2007 1 21
61. Y. Diebold Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP) Biomaterials 28 2007 1553 1564
62. J. Albietz Prevalence of dry eye subtypes in clinical optometric practice Optom. Vis. Sci. 77 2000 357 363
63. S. Moss Prevalence of and risk factors for dry eye syndrome Arch. Ophthalmol. 118 2000 1264 1268
64. M. Doughty A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada Optom. Vis. Sci. 74 1997 624 631
65. K. Nichols Symptoms of ocular irritation in patients diagnosed with dry eye Optom. Vis. Sci. 76 1999 838 844
66. C. Begley Characterization of ocular surface symptoms from optometric practices in North America Cornea 20 2001 610 618